BCLAF1 Antikörper (AA 300-350)
Kurzübersicht für BCLAF1 Antikörper (AA 300-350) (ABIN1977116)
Target
Alle BCLAF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 300-350
-
Spezifität
- Region between residues 300 and 350 of human BCL2 Associated Transcription Factor 1 using the numbering given in entry NP_055554.1 (GeneID 9774).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:50 - 1:500), IHC, IHC-P (1:100 - 1:500), IP (1 - 4 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Ovarian Carcinoma, Prostate Carcinoma, Skin Basal Cell Carcinoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- BCLAF1 (BCL2-Associated Transcription Factor 1 (BCLAF1))
-
Andere Bezeichnung
- BTF / BCLAF1
-
Hintergrund
-
Name/Gene ID: BCLAF1
Family: Apoptosis
Synonyms: BCLAF1, BK211L9.1, BTF, KIAA0164 -
Gen-ID
- 9774
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Target
-